| |
|
|
| |
|
|
| |
Terry Fry, MD
|
|
 |
Center of Excellence, Departments, and Programs
The Center for Cancer and Blood Disorders
Division Chief, Blood and Marrow Transplantation
Division Chief, Immunology
Children’s Research Institute (CRI)
Center for Cancer and Immunology Research
View CRI Profile for Terry Fry
Specialties: Allogeneic Blood and Marrow Transplantation, Autologous Blood and Marrow Transplantation, Bone Marrow Harvests
|
|
| Board Certifications |
American Board of Pediatrics
American Board of Pediatrics/Hematology-Oncology
|
National Provider Identifier
 |
1538360185 |
|
| Practice Locations |
Children's National Medical Center - Main Hospital
111 Michigan Avenue, NW
Washington, DC
Phone: 202-476-5000
 
|
|
| Biography |
Terry Fry, MD, is chief of the Division of Blood and Marrow Transplantation and acting chief of the Divsion of Immunology. His clinical interests include allogeneic hematopoietic stem cell transplantation for malignancies.
Aside from seeing patients at Children's National, Dr. Fry is an adjunct scientist for the Pediatric Oncology Branch at the National Cancer Institute, where he studies immunotherapy for pediatric cancer. He is frequently invited to lecture nationally and internationally.
Dr. Fry lives in Maryland with his wife and three children.
|
|
| Education |
| Type | School | Location | Degree | Field of Study | Years | | Undergraduate Education | Colgate University | Hamilton, NY | Bachelor of Arts | | 1984 -1988 | | Medical School | Georgetown University School of Medicine | Washington, DC | Doctor of Medicine | | 1988 -1992 |
|
|
| Training |
| Type | Institution | Location | Position | Specialty | Years | | Internship Program | Georgetown University Medical Center | Washington, DC | Intern | | 1992 - 1993 | | Residency Program | Georgetown University Hospital | Washington, DC | Resident | | 1993 - 1995 | | Residency Program | Georgetown University Hospital | Washington, DC | | Pediatric Residency | 1995 - 1996 | | Fellowship Program | Johns Hopkins Hospital, Inc | Baltimore, MD | Fellow | | 1996 - 1999 |
|
|
| National and International Recognition |
| Award | Institution | Event | Year | | Ad Hoc Reviewer | National Institutes of Health | Recombinant DNA Advisory Committee | 2007 | | Teaching Award | National Institutes of Health Postbac IRTA Committee | | 2005 |
|
|
| Affiliations and Memberships |
| Title | Institution | Committee / Section | Years | | Vice Chair | Pediatric Blood and Marrow Transplant Consortium | Oncology Strategy Group | 2009 - 2012 | | Member | American Society of Hematology | | 1999 - 2009 | | Member | American Society for Blood and Marrow Transplantat | | 2007 - 2009 | | Member | American Association of Immunologists | | 2003 - 2009 | | Member | National Cancer Institute | Internal Review Board | 2005 - 2007 |
|
|
| Research |
| Title | Study Name | Institution | Years | | Principal Investigator | Pre-clinical and clinical investigations into the mechanisms and efficacy of extracorporeal photopheresis (ECP) in the abrogation of graft-vs-host disease (GVHD) and facilitation of graft-vs-tumor (GVT) immunity in pediatric patients. | National Institutes of Health | 2008 - 2009 | | | Principal Investigator | Targeting solid tumors with dendritic cell vaccines following allogeneic transplantation. | Lisa's Heart Foundation | 2007 - 2008 | | | Principal Investigator | Pre-clinical development of tumor-specific vaccines targeting pediatric ALL following allogeneic stem cell transplantation. | Children's Cancer Foundation Grant. | 2005 - 2008 | | | Read more about the research interests of Terry Fry |
|
|
| Publications |
Journal Article, Capitini C.M., Herby S., Milliron M., Anver M.R., Mackall C.L., Fry T.J.. (2009), Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect., Blood, 113, 20 , 5002-5009.
Journal Article, Fry T.J., Shand J.L., Milliron M., Tasian S.K., Mackall C.L. (2009), Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches, Cancer Immunology Immunotherapy, 58, 8 , 1257-1264.
Journal Article, Dean R.M., Fry T., Mackall C., Steinberg S.M., Hakim F., Fowler D., Odom J., Foley J., Gress R., Bishop M.R. (2008), Association of serum interleukin-7 levels with the development of acute graft-versus-host disease, Journal of Clinical Oncology, 26, 35 , 5735-5741.
Journal Article, Sportès C., Hakim F.T., Memon S.A., Zhang H., Chua K.S., Brown M.R., Fleisher T.A., Krumlauf M.C., Babb R.R., Chow C.K., Fry T.J., Engels J., Buffet R., Morre M., Amato R.J., Venzon D.J., Korngold R., (2008), Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets, Journal of Experimental Medicine, 205, 7 , 1701-1714.
Journal Article, Fry T.J., Lankester A.C. (2008), Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?, Pediatric Clinics of North America, 55, 1 , 147-167.
Journal Article, Chung, Y.J., Choi, C.W., Slape, C., Fry, T., Aplan, P.D. (2008), Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell, Proceedings of the National Academy of Science, 105, 37 , 14088-14093.
Journal Article, Snyder K.M., Mackall C.L., Fry T.J. (2006), IL-7 in allogeneic transplant: clinical promise and potential pitfalls, Leukemia Lymphoma, 47, 7 , 1222-1228.
Journal Article, Fry T.J., Mackall C.L. (2005), The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance, Journal of Immunology, 174, 11 , 6571-6576.
Journal Article, Fry, T.J., Mackall, C.L (2002), IL-7: From bench to clinic, Blood Journal, 99, 3892-3904.
Journal Article, Sinha, M., Fry, T.J., Fowler, D., Miller, G., Mackall, C.L (2002), IL-7 worsens graft versus host disease, Blood Journal, 100, 2642-2649.
For a more comprehensive list of publications for Terry Fry, MD view the National Library of Medicine’s PubMed online database |
|
|
|
|
|
|
